Thorne HealthTech Inc. (THRN)
Company Description
Thorne HealthTech, Inc., a science-driven wellness company, provides solutions and personalized approaches to health and wellness in the United States and internationally.
It offers various health tests, such as sleep, stress, weight management, gut health, heavy metals, biological age, and other health tests that generate molecular portraits for its customers, as well as develops nutritional supplements and offers wellness education solutions.
The company uses the Onegevity platform to map, integrate, and understand the biological features that describe the state of an individual's health, as well as provide actionable insights and personalized data, products, and services that help individuals to take a proactive approach to improve and maintain their health.
It primarily serves healthcare professionals, professional athletes, and professional sports and Olympic teams.
Thorne HealthTech, Inc. was founded in 1984 and is headquartered in New York, New York.

Country | United States |
IPO Date | Sep 23, 2021 |
Industry | Packaged Foods |
Sector | Consumer Defensive |
Employees | 544 |
CEO | Paul F. Jacobson |
Contact Details
Address: 152 West 57th Street New York City, New York United States | |
Website | https://www.thorne.com |
Stock Details
Ticker Symbol | THRN |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001844280 |
CUSIP Number | 885260109 |
ISIN Number | US8852601090 |
Employer ID | 27-2877253 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Nathan D. Price Ph.D. | Chief Scientific Officer & Chief Executive Officer of Onegevity |
Bryan K. Conley | Chief Financial Officer |
Michelle L. Crow | Chief Marketing Officer |
Saloni S. Varma | Chief Financial Officer & Director |
Scott R. Hurth | Chief Technology Officer |
Thomas P. McKenna | Chief Operating Officer & Director |
Dr. Bodi Zhang M.D., MPH, Ph.D. | Chief Strategy Officer |
Kim R. Pearson | Gen. Counsel |
Rob Monteleone | Senior Vice President of Professional Sales |
Thomas Wilson | Vice President & Head of Investor Relations |
William C. McCamy | Pres |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 06, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Oct 26, 2023 | 15-12G | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4 | Filing |
Oct 18, 2023 | 4/A | [Amend] Filing |
Oct 18, 2023 | 4/A | [Amend] Filing |